MASTEC INC
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings Per Share
Note 2 –Earnings Per Share
Basic earnings or loss per share is computed by dividing net income or loss attributable to MasTec by the weighted average number of common shares outstanding for the period, which excludes non-participating unvested restricted share awards. Diluted earnings per share is computed by dividing net income attributable to MasTec by the weighted average number of fully diluted shares, as calculated primarily under the treasury stock method, which includes the potential effect of dilutive common stock equivalents, such as issued but unvested restricted shares.
The following table provides details underlying the Company’s earnings per share calculations for the periods indicated (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Net income (loss) attributable to MasTec: | ||
| Net income (loss) - basic and diluted | $9,903 | $(41,180) |
| Weighted average shares outstanding: | ||
| Weighted average shares outstanding - basic | 78,192 | 77,942 |
| Dilutive common stock equivalents (a) | 860 | — |
| Weighted average shares outstanding - diluted | 79,052 | 77,942 |
(a) For the three month periods ended March 31, 2025 and 2024, anti-dilutive common stock equivalents totaled approximately 55,000 and 727,000, respectively.
Share Repurchases. For the three month period ended March 31, 2025, the Company repurchased 332,565 shares of its common stock, the effect of which on the Company’s weighted average shares outstanding for the related period was minimal. There wereno share repurchases for the three month period ended March 31, 2024. See Note 9 – Equity for details of the Company’s share repurchase transactions, including activity subsequent to March 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.